Sibel Health Raises $39M in Series C Extension Led by Strategic Investors

Deal Summary

Sibel Health closed a $39M Series C extension, bringing total Series C funding to $39M. The extension included strategic investors Maruho Co., Ltd. and Samsung Next and builds on an earlier Series C led by The Steele Foundation for Hope with participation from Dräger.